Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

National Research Corp (NASDAQ:NRCIB)

35.20
Delayed Data
As of Sep 30
 -0.05 / -0.14%
Today’s Change
30.06
Today|||52-Week Range
44.60
-1.73%
Year-to-Date
NRCIB Regular Dividend: NRCIB began trading ex-dividend on 09/28/16. A $0.48 dividend will be paid to shareholders of record as of 09/30/16.
TransUnion Forges Strategic Partnership to Augment Growth
Sep 26 / Zacks.com - Paid Partner Content
Verisk Seeks to Grow with Enhanced Insurance Portfolio
Sep 21 / Zacks.com - Paid Partner Content
Nielsen (NLSN) Proposed Term Loan Gets Moody's Ba1 Rank
Sep 22 / Zacks.com - Paid Partner Content
Verisk (VRSK) Bets on Growth with Insurance Unit Launch
Sep 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close35.25
Today’s open35.24
Day’s range34.85 - 35.95
Volume4,017
Average volume (3 months)4,620
Market cap$124.8M
Dividend yield5.45%
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-4.65%
Earnings growth (this year)+14.79%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+3.55%
P/E ratio12.4
Price/Sales2.46
Price/Book19.90

Competitors

 Today’s
change
Today’s
% change
BIOCBiocept Inc-0.07-4.27%
NRCIANational Research Co...+0.64+4.09%
CEBCEB Inc+1.03+1.93%
Data as of 4:02pm ET, 09/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.19
Annual revenue (last year)$102.3M
Annual profit (last year)$17.5M
Net profit margin17.06%

Profile

Sector
Health Services
Industry
Services to the Health Industry
Chief Executive Officer &
Director
Michael D. Hays
President
Steven D. Jackson
Corporate headquarters
Lincoln, Nebraska

Forecasts

Search for Jobs